Medlogix

Ya estamos en Málaga para el 36 encuentro anual ESHO, promovido por la Sociedad Europea de #Hipertermia Oncológica junto a nuestro partner Medlogix y sus sistemas avanzados de hipertermia oncológica 𝗔𝗟𝗕𝗔. Si tienes pensado acudir, nos encontrarás aquí👇 📍Estand 2 📅Del 6 al 8 de noviembre 🗺️Málaga Más información sobre el sistema 𝗔𝗟𝗕𝗔➡️ https://ow.ly/ANPL50TVeX3

Aplicaciones Tecnológicas de la Física participa la próxima semana en el 36 encuentro anual ESHO, promovido por la Sociedad Europea de #Hipertermia Oncológica con el objetivo de los efectos de esta técnica en el tratamiento contra el cáncer, ya sea sola o combinada con otras modalidades como la #radioterapia. Acudimos al encuentro junto a nuestro partner Medlogix y sus sistemas avanzados de hipertermia oncológica 𝗔𝗟𝗕𝗔. 📍Estand 2 📅Del 6 al 8 de noviembre 🗺️Málaga Más información sobre el sistema 𝗔𝗟𝗕𝗔➡️ https://ow.ly/ANPL50TVeX3

October is Breast Cancer Awareness Month. Let's unite to support, raise awareness, and empower those affected by breast cancer! 🎀 The ALBA team #BreastCancerAwareness #ThinkPink #PinkOctober #StrongerTogether #SupportTheCause #Hyperthermia #CancerTreatment

Medlogix was proud to be present between the 4-6th of October at the 2nd Panhellenic Congress of Medical Physics in Athens, Greece. 🇬🇷 It was a pleasure being invited for a 30 minute presentation with the title “Fast Thermoradiotherapy: RT-like treatment delivery and treatment plan in the radiotherapy department with ALBA precision Hyperthermia”. The full auditorium and the debate demonstrated the growing interest in RT-like #Hyperthermia across Europe, inspiring medical physicists eager to explore and support this powerful combined treatment. We couldn’t be happier for the warm welcome and the excellent collaboration with the Papapostolou Healthcare Technologies team, always aiming to provide innovative cutting-edge technologies throughout Greece. ✨ Ευχαριστούμε πολύ! https://lnkd.in/de-A4AhT https://lnkd.in/eAtSQkGa #Hyperthermia #Thermoradiotherapy #PCMP #HealthcareInnovation #CancerTreatment

On September 5th and 6th, Karolinska Institutet and Stockholm University hosted its biannual workshop, centered on key emerging topics within the radiotherapy (RT) scientific community. This year, The Royal Swedish Academy of Sciences committee identified #Hyperthermia (HT) as a key treatment modality, steadily gaining recognition for its effectiveness when combined with radiotherapy. To provide deeper insights into the current HT status and technology, Dr. Hans Crezee and Dr. Petra Kok from Amsterdam UMC were invited, alongside leading scientists from renowned institutes worldwide. 🇸🇪 The workshop’s primary focus was on the Biologically Equivalent Dose (BED) and the critical parameters to consider when non-conventional fractionation treatments, such as SBRT, SRS, and FLASH, are employed. Discussions also covered RBE and fractionation in proton-, ion-, and neutron radiotherapy, as well as 𝗳𝗿𝗮𝗰𝘁𝗶𝗼𝗻𝗮𝘁𝗶𝗼𝗻 𝗶𝗻 𝗰𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗶𝗼𝗻 𝘁𝗵𝗲𝗿𝗮𝗽𝗶𝗲𝘀, including chemoradiotherapy, immunoradiotherapy, and 𝗵𝘆𝗽𝗲𝗿𝘁𝗵𝗲𝗿𝗺𝗶𝗮 𝗰𝗼𝗺𝗯𝗶𝗻𝗲𝗱 𝘄𝗶𝘁𝗵 𝗿𝗮𝗱𝗶𝗼𝘁𝗵𝗲𝗿𝗮𝗽𝘆. In the context of hyperthermia, data on radiosensitivity parameters (α/β) for different tumor sites under various treatment conditions are already published. This allows the calculation of the EQD2 after a thermoradiotherapy treatment, as presented at #ESTRO'24. Therefore, BED of Radiotherapy (conventional or hypofractionated) in combination with Hyperthermia, can't go to bed❗ #Hyperthermia #Thermoradiotherapy #BED #EQD

https://lnkd.in/dsuQS_PR

🌟 It has been five years since the previous Estro Meets Asia 2019 in Singapore, and we are thrilled and honoured to have been part of this year’s event at the Kuala Lumpur Convention Centre. 🤝It was a fantastic opportunity to reconnect with our valued principals Elekta Medlogix C-RAD AB Orfit PTW Radformation and professionals. We sincerely thank everyone who visited our booth and shared their experiences with us! 🔍 The engagement was remarkable, and the outcomes of the Congress were truly impactful. This event reinforces our dedication to enhancing cancer treatment technologies and driving better patient outcomes worldwide. Here’s to continued progress and collaboration in the fight against cancer! 💪 #EstroMeetsAsia2024 #cancertreatment #Radiotherapy #Thermoradiotherapy #Hyperthermia

#ESTRO met Asia after a 5-year hiatus and we are thrilled to share our experience! 🌏 Medlogix proudly represented at our ABEX Medical System Sdn Bhd partners' booth from August 23-25 in Kuala Lumpur, showcasing the innovative #ALBA precision Hyperthermia product line and demonstrating the impressive effects of Fast #Thermoradiotherapy treatment. Asia's high incidence of advanced-stage cancer patients underscores the critical role of Hyperthermia – an area where this treatment modality might be the only solution. The European Society for Radiotherapy and Oncology (ESTRO) committee recognized this importance, featuring a notable number of oral presentations on Hyperthermia. We're excited to report that excellent clinical outcomes using ALBA ON 4000D and ALBA 4D were presented at the congress, including: 1. Friday 23/08: Impact of locoregional thermoradiation in locally advanced rectal cancer: Prospective phase II trial presented by Dr. Barbara Salas Salas, MD, MSc, PhD from Hospital Universitario de Gran Canaria Doctor Negrín 🇪🇸 2. Saturday 24/08: High thermal dose improves effect in non-muscle-invasive bladder cancer treated with MMC and heating presented by Dr. Hans Crezee from Amsterdam UMC 🇳🇱 3. Saturday 24/08: Strong continuous thermal dose-effect relationship in postoperative recurrent breast cancer patients presented by PhD Student Paola Tello Valverde from Amsterdam UMC 🇳🇱 The remarkable results achieved in our #ALBA centers worldwide are now being shared with clinicians and medical physicists at international congresses. We're particularly proud that Thermoradiotherapy is performed daily across Asia, made possible through our dedicated #ABEX partners. Many thanks to all the visitors who came to the booth. This event reaffirms our commitment to advancing cancer treatment technologies and improving patient outcomes globally. Keep boosting up your dose! #EmA #CancerTreatment #Hyperthermia #Thermoradiotherapy #GlobalHealthcare

La #hipertermia oncológica como adyuvante de la #radioterapia es ya el estándar de tratamiento en Academic Medical Center (AMC) para pacientes con #cáncer de cérvix localmente avanzado, en las que está contraindicada la quimioterapia de platino, y no son aptas para la quimiorradiación estándar. La publicación del AMC remarca la importancia de la dosis térmica, pero también del intervalo de tiempo entre la administración de la hipertermia y la radioterapia. Por ello, es indispensable un equipamiento de hipertermia profunda como el sistema ALBA 4D de Medlogix, capaz de proporcionar un tratamiento eficaz. ⤵️ https://bit.ly/3m2COER #oncologia

El método desarrollado por RaySearch Laboratories, Medlogix y Amsterdam UMC para la planificación conjunta de #hipertermia oncológica y #radioterapia permite optimizar el tratamiento de termorradioterapia 🌡 ⬇ Aplicaciones Tecnológicas de la Física